"aducanumab" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-n-",
        "3": "-umab",
        "t1": "neural",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-n- (“neural”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From -n- (“neural”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "aducanumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -n-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -umab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 2 entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 19, The New York Times, “Greece’s Debt Payments, Apple Earnings and Credit Suisse Results”, in New York Times:",
          "text": "Biogen’s drug, aducanumab, slowed the decline in cognition in an early-stage trial.",
          "type": "quote"
        }
      ],
      "glosses": [
        "A human monoclonal antibody and drug candidate designed for treatment of Alzheimer's disease."
      ],
      "id": "en-aducanumab-en-noun-d6kE7axp",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "candidate",
          "candidate"
        ],
        [
          "Alzheimer's disease",
          "Alzheimer's disease"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human monoclonal antibody and drug candidate designed for treatment of Alzheimer's disease."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "aducanumab"
      ]
    }
  ],
  "word": "aducanumab"
}

{
  "forms": [
    {
      "form": "aducanumabs",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {
        "1": "m"
      },
      "expansion": "aducanumab m (plural aducanumabs)",
      "name": "es-noun"
    }
  ],
  "lang": "Spanish",
  "lang_code": "es",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "Pages with 2 entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Spanish entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "aducanumab"
      ],
      "id": "en-aducanumab-es-noun-BSKvbS17",
      "links": [
        [
          "aducanumab",
          "aducanumab#English"
        ]
      ],
      "tags": [
        "masculine"
      ]
    }
  ],
  "word": "aducanumab"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "-n-",
        "3": "-umab",
        "t1": "neural",
        "t2": "human monoclonal antibody"
      },
      "expansion": "-n- (“neural”) + -umab (“human monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From -n- (“neural”) + -umab (“human monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "aducanumab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms interfixed with -n-",
        "English terms suffixed with -umab",
        "English terms with quotations",
        "English uncountable nouns",
        "Pages with 2 entries",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2015 July 19, The New York Times, “Greece’s Debt Payments, Apple Earnings and Credit Suisse Results”, in New York Times:",
          "text": "Biogen’s drug, aducanumab, slowed the decline in cognition in an early-stage trial.",
          "type": "quote"
        }
      ],
      "glosses": [
        "A human monoclonal antibody and drug candidate designed for treatment of Alzheimer's disease."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "drug",
          "drug"
        ],
        [
          "candidate",
          "candidate"
        ],
        [
          "Alzheimer's disease",
          "Alzheimer's disease"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human monoclonal antibody and drug candidate designed for treatment of Alzheimer's disease."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "aducanumab"
      ]
    }
  ],
  "word": "aducanumab"
}

{
  "forms": [
    {
      "form": "aducanumabs",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {
        "1": "m"
      },
      "expansion": "aducanumab m (plural aducanumabs)",
      "name": "es-noun"
    }
  ],
  "lang": "Spanish",
  "lang_code": "es",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "Pages with 2 entries",
        "Pages with entries",
        "Spanish countable nouns",
        "Spanish entries with incorrect language header",
        "Spanish lemmas",
        "Spanish masculine nouns",
        "Spanish nouns"
      ],
      "glosses": [
        "aducanumab"
      ],
      "links": [
        [
          "aducanumab",
          "aducanumab#English"
        ]
      ],
      "tags": [
        "masculine"
      ]
    }
  ],
  "word": "aducanumab"
}